Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07892872) titled 'Effect of MxA Guidance on Antiviral Treatment in Respiratory Viral Infections' on Oct. 18.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Capital Medical University
Condition:
Respiratory Viral Infections
Influenza
SARS CoV 2 Infection
Intervention:
Other: Baseline MxA testing
Other: Serial MxA testing
Other: MxA result feedback and antiviral treatment recommendations
Other: Follow-up at Day 30
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: Nov...